Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Novitzky

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|August 23, 2005
Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted graftsN Novitzky, V Thomas, G Hale, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 30, 2017
Recommendations for the use of immunoglobulin therapy for immunomodulation and antibody replacementJ G Peter, J M Heckmann, N Novitzky
Cytotherapy|June 19, 2004
Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experienceN Novitzky, V Thomas, G Hale, et al.
International Journal of Laboratory Hematology|December 2, 2010
The diagnostic utility of bone marrow biopsies performed for the investigation of fever and/or cytopenias in HIV-infected adults at Groote Schuur Hospital, Western Cape, South AfricaW A van Schalkwyk, J Opie, N Novitzky
Bone Marrow Transplantation|December 17, 2008
Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHDN Novitzky, V Thomas, C du Toit, et al.
Experimental Hematology|September 16, 2000
Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromesN Novitzky, R Mohamed, J Finlayson, et al.
American Journal of Hematology|June 1, 1995
Treatment of aggressive non-Hodgkin's lymphoma in the elderlyN Novitzky, H S King, C Johnson, et al.
Intensive Care Medicine|November 15, 2023
Decidual stromal cells for the treatment of severe COVID-19 ARDSJohn Granton, Igor N Novitzky-Basso, Alexandra Binnie, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 7, 1999
Factor V Leiden gene mutation in three South African familiesR Rubinstein, D Bowers, N Novitzky, et al.
Cytotherapy|October 30, 2004
Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasiaN Novitzky, V Thomas, H Stubbings, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|August 23, 2005
Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted graftsN Novitzky, V Thomas, G Hale, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 30, 2017
Recommendations for the use of immunoglobulin therapy for immunomodulation and antibody replacementJ G Peter, J M Heckmann, N Novitzky
Cytotherapy|June 19, 2004
Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experienceN Novitzky, V Thomas, G Hale, et al.
International Journal of Laboratory Hematology|December 2, 2010
The diagnostic utility of bone marrow biopsies performed for the investigation of fever and/or cytopenias in HIV-infected adults at Groote Schuur Hospital, Western Cape, South AfricaW A van Schalkwyk, J Opie, N Novitzky
Bone Marrow Transplantation|December 17, 2008
Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHDN Novitzky, V Thomas, C du Toit, et al.
Experimental Hematology|September 16, 2000
Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromesN Novitzky, R Mohamed, J Finlayson, et al.
American Journal of Hematology|June 1, 1995
Treatment of aggressive non-Hodgkin's lymphoma in the elderlyN Novitzky, H S King, C Johnson, et al.
Intensive Care Medicine|November 15, 2023
Decidual stromal cells for the treatment of severe COVID-19 ARDSJohn Granton, Igor N Novitzky-Basso, Alexandra Binnie, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 7, 1999
Factor V Leiden gene mutation in three South African familiesR Rubinstein, D Bowers, N Novitzky, et al.
Cytotherapy|October 30, 2004
Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasiaN Novitzky, V Thomas, H Stubbings, et al.
Pageof 11